Mutations in PTCH are associated with Basal Cell Nevus Syndrome (Gorlin syndrome), which increases the risk of developing basal cell carcinoma and other tumors like medulloblastoma. Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.